Cargando…
Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug–drug interactions and hepatitis C cure
Background Human immunodeficiency virus (HIV) co-infection and chronic kidney disease add challenges to hepatitis C virus treatment. Objective To conduct a comparative study of treatment choices, drug–drug interactions and clinical outcomes in hepatitis C mono-infected patients, or those with HIV or...
Autores principales: | Ali, Salamat, Ur-Rehman, Tofeeq, Lougher, Eleri, Mutimer, David, Ali, Mashhood, Paudyal, Vibhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192872/ https://www.ncbi.nlm.nih.gov/pubmed/32100238 http://dx.doi.org/10.1007/s11096-020-00994-6 |
Ejemplares similares
-
Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme
por: Ali, Salamat, et al.
Publicado: (2020) -
Complementary and Alternative Medicines for the Treatment of Hepatitis C: Perspectives of Users and CAM Practitioners
por: Ali, Salamat, et al.
Publicado: (2020) -
A Randomized Controlled Trial to Assess the Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients
por: Ali, Salamat, et al.
Publicado: (2019) -
Illness perception about hepatitis C virus infection: a cross-sectional study from Khyber Pakhtunkhwa Pakistan
por: Ullah, Shahan, et al.
Publicado: (2022) -
Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy
por: Khalid, Javeria, et al.
Publicado: (2020)